Log in

Treatments and in-hospital mortality in acute myocardial infarction patients with rheumatoid arthritis: a nationwide retrospective cohort study in Japan

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

No previous study has examined the differences in treatments and outcomes after acute myocardial infarction (AMI) between patients with and without rheumatoid arthritis (RA) in a setting where coronary reperfusion therapy was readily available. This study aimed to examine whether coexisting RA affected likelihood of receiving coronary reperfusion therapy and in-hospital mortality among AMI patients in a Japanese nationwide setting where coronary reperfusion therapy was readily available. Using the Diagnosis Procedure Combination database, we retrospectively identified patients admitted with AMI between 2010 and 2014 and created a matched-pair cohort of patients with and without RA based on age, sex, hospital, and admission year at a maximum ratio of 1:5. We performed multivariable logistic regression analyses for associations of RA with likelihood of coronary reperfusion therapy and 30-day in-hospital mortality. There were no significant differences between the RA group (n = 938) and non-RA group (n = 3839) in the proportions of patients receiving coronary reperfusion therapy (on the day of admission 75.8% vs. 77.2%, P = 0.364; during hospitalization 87.1% vs. 87.3%, P = 0.913) and 30-day in-hospital mortality (5.9% vs. 5.9%, P = 1.000). Multivariable logistic regression analyses showed that RA was not significantly associated with either likelihood of receiving coronary reperfusion therapy during hospitalization (odds ratio 1.02; 95% confidence interval 0.82–1.27; P = 0.837) or 30-day in-hospital mortality (odds ratio 1.16; 95% confidence interval 0.81–1.65; P = 0.419). Coexisting RA did not affect likelihood of receiving coronary reperfusion therapy or in-hospital mortality among AMI patients in a setting where reperfusion therapy was readily available.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ et al (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52:402–411

    Article  PubMed  Google Scholar 

  2. Symmons DP, Gabriel SE (2011) Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7:399–408

    Article  PubMed  Google Scholar 

  3. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J (2005) Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 35:8–17

    Article  PubMed  Google Scholar 

  4. Rho YH, Chung CP, Oeser A, Solus J, Asanuma Y, Sokka T et al (2009) Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 61:1580–1585

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Norgard B, Friis S et al (2005) Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med 165:978–984

    Article  CAS  PubMed  Google Scholar 

  6. Hippisley-Cox J, Coupland C (2005) Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 330:1366

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM et al (2007) Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 56:820–830

    Article  CAS  PubMed  Google Scholar 

  8. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697

    Article  PubMed  Google Scholar 

  9. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 71:1524–1529

    Article  PubMed  Google Scholar 

  10. Van Doornum S, Brand C, King B, Sundararajan V (2006) Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum 54:2061–2068

    Article  CAS  PubMed  Google Scholar 

  11. Van Doornum S, Brand C, Sundararajan V, Ajani AE, Wicks IP (2010) Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population. Arthritis Res Ther 12:R183

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sodergren A, Stegmayr B, Lundberg V, Ohman ML, Wallberg-Jonsson S (2007) Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis. Ann Rheum Dis 66:263–266

    Article  PubMed  Google Scholar 

  13. McCoy SS, Crowson CS, Maradit-Kremers H, Therneau TM, Roger VL, Matteson EL et al (2013) Long-term outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. J Rheumatol 40:605–610

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Francis ML, Varghese JJ, Mathew JM, Koneru S, Scaife SL, Zahnd WE (2010) Outcomes in patients with rheumatoid arthritis and myocardial infarction. Am J Med 123:922–928

    Article  PubMed  Google Scholar 

  15. Mantel A, Holmqvist M, Jernberg T, Wallberg-Jonsson S, Askling J (2015) Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome. Eur Heart J 36:3413–3422

    Article  PubMed  Google Scholar 

  16. Ui S, Chino M, Isshiki T (2005) Rates of primary percutaneous coronary intervention worldwide. Circ J 69:95–100

  17. Isogai T, Yasunaga H, Matsui H, Tanaka H, Ueda T, Horiguchi H et al (2015) Effect of weekend admission for acute myocardial infarction on in-hospital mortality: a retrospective cohort study. Int J Cardiol 179:315–320

    Article  PubMed  Google Scholar 

  18. Yamana H, Matsui H, Sasabuchi Y, Fushimi K, Yasunaga H (2015) Categorized diagnoses and procedure records in an administrative database improved mortality prediction. J Clin Epidemiol 68:1028–1035

    Article  PubMed  Google Scholar 

  19. Hashimoto H, Ikegami N, Shibuya K, Izumida N, Noguchi H, Yasunaga H et al (2011) Cost containment and quality of care in Japan: is there a trade-off? Lancet 378:1174–1182

    Article  PubMed  Google Scholar 

  20. Killip T 3rd, Kimball JT (1967) Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20:457–464

    Article  PubMed  Google Scholar 

  21. DeGeare VS, Boura JA, Grines LL, O’Neill WW, Grines CL (2001) Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 87:1035–1038

    Article  CAS  PubMed  Google Scholar 

  22. Khot UN, Jia G, Moliterno DJ, Lincoff AM, Khot MB, Harrington RA et al (2003) Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA 290:2174–2181

    Article  CAS  PubMed  Google Scholar 

  23. Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173:676–682

    Article  PubMed  Google Scholar 

  24. Rubin DB, Schenker N (1991) Multiple imputation in health-care databases: an overview and some applications. Stat Med 10:585–598

    Article  CAS  PubMed  Google Scholar 

  25. van Buuren S, Boshuizen HC, Knook DL (1999) Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 18:681–694

    Article  PubMed  Google Scholar 

  26. Saeki Y, Matsui T, Saisho K, Tohma S (2012) Current treatments of rheumatoid arthritis: from the “NinJa” registry. Expert Rev Clin Immunol 8:455–465

    Article  CAS  PubMed  Google Scholar 

  27. Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F et al (2009) Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 11:R7

    PubMed  PubMed Central  Google Scholar 

  28. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F et al (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the Management of Acute Coronary Syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37:267–315

    Article  PubMed  Google Scholar 

  29. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr et al (2014) 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 130:e344–e426

    Article  PubMed  Google Scholar 

  30. O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 127:e362–e425

    Article  PubMed  Google Scholar 

  31. Aubry MC, Maradit-Kremers H, Reinalda MS, Crowson CS, Edwards WD, Gabriel SE (2007) Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 34:937–942

    CAS  PubMed  Google Scholar 

  32. Karpouzas GA, Malpeso J, Choi TY, Li D, Munoz S, Budoff MJ (2014) Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis 73:1797–1804

    Article  PubMed  Google Scholar 

  33. Pedersen F, Butrymovich V, Kelbaek H, Wachtell K, Helqvist S, Kastrup J et al (2014) Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol 64:2101–2108

    Article  PubMed  Google Scholar 

  34. Toyota T, Furukawa Y, Ehara N, Funakoshi S, Morimoto T, Kaji S et al (2013) Sex-based differences in clinical practice and outcomes for Japanese patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J 77:1508–1517

    Article  PubMed  Google Scholar 

  35. Park JS, Kim YJ, Shin DG, Jeong MH, Ahn YK, Chung WS et al (2010) Gender differences in clinical features and in-hospital outcomes in ST-segment elevation acute myocardial infarction: from the Korean Acute Myocardial Infarction Registry (KAMIR) study. Clin Cardiol 33:E1–E6

    Article  PubMed  Google Scholar 

  36. Sadowski M, Gasior M, Gierlotka M, Janion M, Polonski L (2011) Gender-related differences in mortality after ST-segment elevation myocardial infarction: a large multicentre national registry. EuroIntervention 6:1068–1072

    Article  PubMed  Google Scholar 

  37. Kosuge M, Kimura K, Ishikawa T, Ebina T, Hibi K, Tsukahara K et al (2006) Differences between men and women in terms of clinical features of ST-segment elevation acute myocardial infarction. Circ J 70:222–226

    Article  PubMed  Google Scholar 

  38. Kirchberger I, Heier M, Kuch B, Wende R, Meisinger C (2011) Sex differences in patient-reported symptoms associated with myocardial infarction (from the population-based MONICA/KORA myocardial infarction registry). Am J Cardiol 107:1585–1589

    Article  PubMed  Google Scholar 

  39. Canto JG, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V et al (2012) Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 307:813–822

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H (2016) Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. doi:10.1016/j.je.2016.09.009

  41. Wilchesky M, Tamblyn RM, Huang A (2004) Validation of diagnostic codes within medical services claims. J Clin Epidemiol 57:131–141

    Article  PubMed  Google Scholar 

  42. Quan H, Li B, Saunders LD, Parsons GA, Nilsson CI, Alibhai A et al (2008) Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res 43:1424–1441

    Article  PubMed  PubMed Central  Google Scholar 

  43. Januel JM, Luthi JC, Quan H, Borst F, Taffe P, Ghali WA et al (2011) Improved accuracy of co-morbidity coding over time after the introduction of ICD-10 administrative data. BMC Health Serv Res 11:194

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Toshiaki Isogai.

Ethics declarations

This study was approved by the Institutional Review Board at The University of Tokyo. The requirement for informed consent was waived because of the anonymized nature of the data in the database.

Disclosures

None.

Funding

This work was supported by Grants for Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare, Japan (Grant Numbers H27-Policy-Designated-009 and H28-Policy-Strategy-011). The funders had no role in the execution of this study or the interpretation of the results.

Electronic supplementary material

ESM 1

(DOCX 826 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Isogai, T., Matsui, H., Tanaka, H. et al. Treatments and in-hospital mortality in acute myocardial infarction patients with rheumatoid arthritis: a nationwide retrospective cohort study in Japan. Clin Rheumatol 36, 995–1004 (2017). https://doi.org/10.1007/s10067-017-3555-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3555-3

Keywords

Navigation